文献速递妇产影像心血管US

胎儿动脉导管收缩逆转后肺动脉高压与成熟度的改善:前瞻性队列研究

Improvement in fetal pulmonary hypertension and maturity after reversal of ductal constriction: prospective cohort study.
PubMed 文献 · Ultrasound Obstet Gynecol · 2021-01-01

本研究为前瞻性队列研究,纳入70例孕晚期(≥28周)胎儿动脉导管收缩病例,在减少母体前列腺素抑制剂摄入2周后,动脉导管流速和搏动指数恢复正常,估测平均肺动脉压(MPAP)从66.7 mmHg降至54.5 mmHg,肺动脉AT/ET比值从0.20升至0.33(均P<0.001),且变化幅度显著大于同孕周305例正常胎儿。

要点

  • 胎儿动脉导管收缩在减少母体前列腺素抑制剂摄入2周后,导管流速及搏动指数恢复正常。
  • 逆转后MPAP下降(66.7→54.5 mmHg),AT/ET比值升高(0.20→0.33),均P<0.001。
  • MPAP变化幅度为正常胎儿的5.3倍,AT/ET变化幅度为正常胎儿的8.7倍。

关键影像表现/征象

  • 动脉导管收缩时导管收缩期峰值流速1.86±0.34 m/s,舒张期流速0.41±0.11 m/s,搏动指数1.99±0.20。
  • 减少母体前列腺素抑制剂摄入2周后,导管收缩期流速降至1.38±0.41 m/s,舒张期流速降至0.21±0.065 m/s,搏动指数升至2.55±0.42(均P<0.001)。
  • 诊断时MPAP为66.7±6.90 mmHg,2周后降至54.5±6.70 mmHg(P<0.001)。
  • 诊断时肺动脉AT/ET比值为0.20±0.06,2周后升至0.33±0.07(P<0.001)。

诊断标准与关键数值

  • MPAP采用Dabestani方程估算:MPAP = 90 - (0.62 × AT)。
  • 肺动脉血管成熟度采用肺动脉血流加速时间与射血时间比值(AT/ET比值)评估。
  • 研究组MPAP变化为-12.2±0.30 mmHg,为同孕周305例正常胎儿2周变化(-2.3±0.19 mmHg)的5.3倍(P<0.001)。
  • 研究组AT/ET比值变化为0.13±0.08,为同孕周正常胎儿(0.015±0.08)的8.7倍(P<0.001)。

临床应用与阅片要点

  • 对于胎儿动脉导管收缩,减少母体前列腺素抑制剂(如多酚丰富食物或非甾体抗炎药)摄入2周后复查多普勒超声,可观察到导管流速和搏动指数恢复正常。
  • MPAP和肺动脉AT/ET比值可用于评估导管收缩逆转后的血流动力学和血管成熟度改善。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVES: To test the hypotheses that estimated mean pulmonary arterial pressure (MPAP) decreases and pulmonary vascular maturation, assessed by the ratio of pulmonary arterial flow acceleration time to ejection time (AT/ET ratio), increases after reversal of fetal ductus arteriosus constriction by reducing maternal intake of the causal agent (prostaglandin inhibitors, such as polyphenol-rich foods or non-steroidal anti-inflammatory drugs), and that these effects are independent of gestational age, which are inferences not yet demonstrated in the clinical setting.

METHODS: This was a prospective cohort study comparing Doppler echocardiographic ductal flow dynamics, MPAP and pulmonary arterial flow AT/ET ratio in third-trimester fetuses (≥ 28 weeks' gestation) with ductus arteriosus constriction, at the time of diagnosis and after 2 weeks of reduced maternal intake of prostaglandin inhibitors either by suspending the use of pharmacological agents with potential for prostaglandin inhibition or by restricting the consumption of polyphenol-rich foods. MPAP was estimated using the Dabestani equation (MPAP = 90 - (0.62 × AT)), and pulmonary vascular maturity was assessed using the AT/ET ratio, according to reported validation studies. Student's t-test was used for comparison of variables at diagnosis with those after reversal of ductal constriction. Change in MPAP and pulmonary AT/ET ratio between the two assessments was compared with the expected change in the same gestational period in normal fetuses based on reference curves of MPAP and pulmonary AT/ET ratio constructed in normal fetuses from healthy pregnant women at 19-37 weeks' gestation, encompassing the same gestational age range as the study group (28-37 weeks).

RESULTS: Seventy pregnancies with fetal ductus arteriosus constriction were included in the study. After 2 weeks of reduced maternal intake of prostaglandin inhibitors, normalization of mean systolic (change from 1.86 ± 0.34 m/s at diagnosis to 1.38 ± 0.41 m/s; P < 0.001) and diastolic (change from 0.41 ± 0.11 m/s to 0.21 ± 0.065 m/s; P < 0.001) ductal velocities and of mean pulsatility index (change from 1.99 ± 0.20 to 2.55 ± 0.42; P < 0.001) was demonstrated. MPAP decreased between the assessments (change from 66.7 ± 6.90 mmHg at diagnosis to 54.5 ± 6.70 mmHg after 2 weeks; P < 0.001) and mean pulmonary AT/ET ratio increased (change from 0.20 ± 0.06 to 0.33 ± 0.07; P < 0.001). Change in MPAP between diagnosis and after 2 weeks of reduced maternal intake of prostaglandin inhibitors was -12.2 ± 0.30 mmHg, which was 5.3-times higher than that in 305 normal fetuses over 2 weeks during the same gestational period (-2.3 ± 0.19 mmHg) (P < 0.001), and change in pulmonary AT/ET ratio between the two assessments was 0.13 ± 0.08, which was 8.7-times higher than that in normal fetuses in the same gestational period (0.015 ± 0.08) (P < 0.001).

CONCLUSIONS: Resolution of fetal ductal constriction is followed by a fall in MPAP and by an increase in pulmonary vascular maturity, to a significantly greater degree than is observed in normal fetuses in the same gestational-age period. © 2021 International Society of Ultrasound in Obstetrics and Gynecology.

来源:Ultrasound Obstet Gynecol,查看原文。版权归原作者所有。

引用

  1. Zielinsky P, MagalhÃes GA, Zurita-Peralta J, et al. Improvement in fetal pulmonary hypertension and maturity after reversal of ductal constriction: prospective cohort study. Ultrasound Obstet Gynecol. 2021. PMID: 33502049. doi:10.1002/uog.23599

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。